Publications by authors named "R Navardauskaite"
Article Synopsis
- The study aimed to evaluate the quality of life (QoL) and mood states in patients with childhood-onset hypopituitarism and growth hormone deficiency as they stopped recombinant growth hormone therapy during the transition from adolescence to adulthood.
- A total of 136 patients and 82 control individuals were assessed using the Profile of Mood States2 (POMS2) and the Quality of Life - Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) questionnaires.
- Results showed that while overall QoL was similar between the groups, patients experienced significantly higher levels of tension, depression, fatigue, and confusion compared to controls, with various factors such as cortisol levels, height, BMI, and age at therapy discontinuation correl
Aim Of The Study: To evaluate the clinical characteristics and treatment efficacy of patients with severe primary IGF-1 deficiency (PSIGFD) using a recombinant IGF-1 (rhIGF-1).
Objectives Of The Study: To examine the clinical characteristics of patients with PSIGFD before starting treatment with a rIGF-1. To assess the height changes in patients with PSIGFD, before and after treatment with a rhIGF-1.
Background: The effects of long-term glucocorticoid (GC) treatment on bone mineral density (BMD) in patients with congenital adrenal hyperplasia (CAH) remain controversial.
Objectives: This cross-sectional study aimed to evaluate BMD in relation to genotype, growth, vitamin D status, cumulative GC doses, and other relevant factors in youths with CAH.
Methods: Thirty-two patients with classical CAH (13 males; mean age 26.
Background: Although differentiated thyroid carcinoma (DTC) is the most frequent endocrine pediatric cancer, it is rare in childhood and adolescence. While tumor persistence and recurrence are not uncommon, mortality remains extremely low. Complications of treatment are however reported in up to 48% of the survivors.
View Article and Find Full Text PDFAim: The aim was to assess perceived psychological stress, emotional state, and quality of life (QoL) in men and women with congenital adrenal hyperplasia (CAH) in comparison to age- and sex-matched control individuals.
Methods: Participants: 26 patients with CAH (11 men, 15 women, age 14-48 years) and 26 age- and sex-matched control individuals without CAH. Psychological assessment: Perceived Stress Scale, Profile of Mood States2, and WHO Brief Quality of Life Questionnaire.